Amphetamine Addiction
11
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction
Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction
Cannabioids as a New Intervention for Amphetamine Dependence
The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction
The Novel Addiction Assessment Study in Synthetic Drugs Addiction
Novel Intervention for Amphetamine-type Stimulants Addiction
The Application of Music Therapy in Female Amphetamine Use Disorder
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
The Diagnostic Assessment and Intervention Study of Amphetamine Type Stimulus